Works matching IS 03331024 AND DT 2023 AND VI 43 AND IP 2
Results: 22
Epicranial headache part 1: Primary stabbing headache.
- Published in:
- Cephalalgia, 2023, v. 43, n. 2, p. 1, doi. 10.1177/03331024221146985
- By:
- Publication type:
- Article
Genome-wide DNA methylation analysis in an antimigraine-treated preclinical model of cortical spreading depolarization.
- Published in:
- Cephalalgia, 2023, v. 43, n. 2, p. 1, doi. 10.1177/03331024221146317
- By:
- Publication type:
- Article
New migraine prophylactic drugs: Current evidence and practical suggestions for non-responders to prior therapy.
- Published in:
- Cephalalgia, 2023, v. 43, n. 2, p. 1, doi. 10.1177/03331024221146315
- By:
- Publication type:
- Article
Update in the understanding of new daily persistent headache.
- Published in:
- Cephalalgia, 2023, v. 43, n. 2, p. 1, doi. 10.1177/03331024221146314
- By:
- Publication type:
- Article
Migraine genetics: Status and road forward.
- Published in:
- Cephalalgia, 2023, v. 43, n. 2, p. 1, doi. 10.1177/03331024221145962
- By:
- Publication type:
- Article
The impact of epigenetic mechanisms in migraine: Current knowledge and future directions.
- Published in:
- Cephalalgia, 2023, v. 43, n. 2, p. 1, doi. 10.1177/03331024221145916
- By:
- Publication type:
- Article
Longitudinal differences in iron deposition in periaqueductal gray matter and anterior cingulate cortex are associated with response to erenumab in migraine.
- Published in:
- Cephalalgia, 2023, v. 43, n. 2, p. 1, doi. 10.1177/03331024221144783
- By:
- Publication type:
- Article
Persistent headache attributed to past cervicocephalic artery dissection: clinical characteristics and contributors to headache persistence.
- Published in:
- Cephalalgia, 2023, v. 43, n. 2, p. 1, doi. 10.1177/03331024221144782
- By:
- Publication type:
- Article
Additional effects of pain neuroscience education combined with physiotherapy on the headache frequency of adult patients with migraine: A randomized controlled trial.
- Published in:
- Cephalalgia, 2023, v. 43, n. 2, p. 1, doi. 10.1177/03331024221144781
- By:
- Publication type:
- Article
Place of next generation acute migraine specific treatments among triptans, non-responders and contraindications to triptans and possible combination therapies.
- Published in:
- Cephalalgia, 2023, v. 43, n. 2, p. 1, doi. 10.1177/03331024221143773
- By:
- Publication type:
- Article
Greater occipital nerve blockade for the preventive treatment of chronic migraine: A randomized double-blind placebo-controlled study.
- Published in:
- Cephalalgia, 2023, v. 43, n. 2, p. 1, doi. 10.1177/03331024221143541
- By:
- Publication type:
- Article
Association between iron deficiency anemia and chronic daily headache: A case-control study.
- Published in:
- Cephalalgia, 2023, v. 43, n. 2, p. 1, doi. 10.1177/03331024221143540
- By:
- Publication type:
- Article
Alopecia as an emerging adverse event to CGRP monoclonal antibodies: Cases Series, evaluation of FAERS, and literature review.
- Published in:
- Cephalalgia, 2023, v. 43, n. 2, p. 1, doi. 10.1177/03331024221143538
- By:
- Publication type:
- Article
Efficacy of rimegepant for the acute treatment of migraine based on triptan treatment experience: Pooled results from three phase 3 randomized clinical trials.
- Published in:
- Cephalalgia, 2023, v. 43, n. 2, p. 1, doi. 10.1177/03331024221141686
- By:
- Publication type:
- Article
OnabotulinumtoxinA effects on trigeminal nociceptors.
- Published in:
- Cephalalgia, 2023, v. 43, n. 2, p. 1, doi. 10.1177/03331024221141683
- By:
- Publication type:
- Article
Outcome of epidural blood patch for imaging-negative spontaneous intracranial hypotension.
- Published in:
- Cephalalgia, 2023, v. 43, n. 2, p. 1, doi. 10.1177/03331024221140471
- By:
- Publication type:
- Article
Shared genetics and causal relationships between migraine and thyroid function traits.
- Published in:
- Cephalalgia, 2023, v. 43, n. 2, p. 1, doi. 10.1177/03331024221139253
- By:
- Publication type:
- Article
Intra- and interindividual attack frequency variability of chronic cluster headache.
- Published in:
- Cephalalgia, 2023, v. 43, n. 2, p. 1, doi. 10.1177/03331024221139239
- By:
- Publication type:
- Article
Long-term open-label and real-world studies of lasmiditan, ubrogepant, and rimegepant for the acute treatment of migraine attacks.
- Published in:
- Cephalalgia, 2023, v. 43, n. 2, p. 1, doi. 10.1177/03331024221137092
- By:
- Publication type:
- Article
Open-label trials for CGRP-targeted drugs in migraine prevention: A narrative review.
- Published in:
- Cephalalgia, 2023, v. 43, n. 2, p. 1, doi. 10.1177/03331024221137091
- By:
- Publication type:
- Article
Prolactin in headache and migraine: A systematic review of clinical studies.
- Published in:
- Cephalalgia, 2023, v. 43, n. 2, p. 1, doi. 10.1177/03331024221136286
- By:
- Publication type:
- Article
Functional magnetic resonance imaging in migraine: A systematic review.
- Published in:
- Cephalalgia, 2023, v. 43, n. 2, p. 1, doi. 10.1177/03331024221128278
- By:
- Publication type:
- Article